Detalles de la búsqueda
1.
Practical Singly and Doubly Electrophilic Aminating Agents: A New, More Sustainable Platform for Carbon-Nitrogen Bond Formation.
J Am Chem Soc
; 139(32): 11184-11196, 2017 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28648054
2.
Correction to "Practical Singly and Doubly Electrophilic Aminating Agents: A New, More Sustainable Platform for Carbon-Nitrogen Bond Formation".
J Am Chem Soc
; 141(7): 3315, 2019 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724562
3.
Do people agree on how they and others are acting? Examining the degree of target-observer and observer-observer agreement about current behavior as it changes across situations.
J Pers Soc Psychol
; 124(1): 215-235, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36301277
4.
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.
Cell Chem Biol
; 30(10): 1191-1210.e20, 2023 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37557181
5.
Study of the PDK1/AKT signaling pathway using selective PDK1 inhibitors, HCS, and enhanced biochemical assays.
Anal Biochem
; 414(2): 179-86, 2011 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21402045
6.
Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen.
Therapie
; 76(6): 567-576, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589316
7.
Design and Characterization of a Pyridone-Containing EZH2 Inhibitor Phosphate Prodrug.
J Med Chem
; 64(3): 1725-1732, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529029
8.
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.
J Med Chem
; 64(13): 9056-9077, 2021 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110834
9.
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195).
J Med Chem
; 64(1): 644-661, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33356246
10.
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Cancer Cell
; 39(10): 1404-1421.e11, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520734
11.
RNA processing defects associated with diseases of the motor neuron.
Muscle Nerve
; 41(1): 5-17, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19697368
12.
Multifaceted Substrate-Ligand Interactions Promote the Copper-Catalyzed Hydroboration of Benzylidenecyclobutanes and Related Compounds.
ACS Catal
; 10(21): 13075-13083, 2020 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33791144
13.
Solution-phase parallel synthesis of Hsp90 inhibitors.
J Comb Chem
; 11(5): 860-74, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19583220
14.
Inpatient, Outpatient, and Pharmacy Costs in Patients With and Without HIV in the US Veteran's Affairs Administration System.
J Int Assoc Provid AIDS Care
; 18: 2325958219855377, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31213120
15.
Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497).
J Med Chem
; 61(3): 650-665, 2018 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29211475
16.
Climatic and geographic predictors of life history variation in Eastern Massasauga (Sistrurus catenatus): A range-wide synthesis.
PLoS One
; 12(2): e0172011, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28196149
17.
Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.
Nat Commun
; 7: 11384, 2016 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27122193
18.
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.
J Med Chem
; 59(18): 8306-25, 2016 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27512831
19.
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants.
J Med Chem
; 59(5): 2005-24, 2016 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26756222
20.
Activities of the USP Analytical Microbiology Expert Committee during the 2000-2005 revision cycle.
PDA J Pharm Sci Technol
; 59(3): 157-76, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16048116